Allergic contact dermatitis from carteolol and timolol in eyedrops.
Quiralte
J
J
Unidad de Alergia, Hospital Ciudad de Jaén, Spain.
Florido
F
F
de San Pedro
B S
BS
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D002354:Carteolol / Q000009:adverse effects* / Q000627:therapeutic use; D003429:Cross Reactions; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000209:etiology*; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D005143:Eyelids; D005902:Glaucoma, Open-Angle / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions / Q000009:adverse effects; D010328:Patch Tests; D011379:Prognosis; D013999:Timolol / Q000009:adverse effects* / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D013999:Timolol; D002354:Carteolol